2.5 mg tirzepatide New Access and Pricing Through Self-Pay Options Zeptide (Tirzepatide) 2.5 mg Prefilled

Food & Drug Administration, Update on FDAs ongoing evaluation of reports of suicidal thoughts or actions in patients taking a certain type of medicines approved for type 2 diabetes and obesity (2024)

2 Which weight-loss injection is right for me

Sold under the brand name Rezdiffra, this medication was approved on March 14, 2024, for the treatment of nonalcoholic steatohepatitis or NASH (since renamed to metabolic dysfunction-associated steatohepatitis or MASH) with moderate to advanced liver scarring

The Triple Threat: Retatrutides Glucagon Component Retatrutide is often referred to as a GIP GLP-1 Glucagon agonist , setting it apart as the first drug of its kind to target three distinct metabolic pathways

This product is strictly for laboratory and investigational use only